Breaking the Gingival Barrier in Periodontitis

Int J Mol Sci. 2023 Feb 25;24(5):4544. doi: 10.3390/ijms24054544.

Abstract

The break of the epithelial barrier of gingiva has been a subject of minor interest, albeit playing a key role in periodontal pathology, transitory bacteraemia, and subsequent systemic low-grade inflammation (LGI). The significance of mechanically induced bacterial translocation in gingiva (e.g., via mastication and teeth brushing) has been disregarded despite the accumulated knowledge of mechanical force effects on tight junctions (TJs) and subsequent pathology in other epithelial tissues. Transitory bacteraemia is observed as a rule in gingival inflammation, but is rarely observed in clinically healthy gingiva. This implies that TJs of inflamed gingiva deteriorate, e.g., via a surplus of lipopolysaccharide (LPS), bacterial proteases, toxins, Oncostatin M (OSM), and neutrophil proteases. The inflammation-deteriorated gingival TJs rupture when exposed to physiological mechanical forces. This rupture is characterised by bacteraemia during and briefly after mastication and teeth brushing, i.e., it appears to be a dynamic process of short duration, endowed with quick repair mechanisms. In this review, we consider the bacterial, immune, and mechanical factors responsible for the increased permeability and break of the epithelial barrier of inflamed gingiva and the subsequent translocation of both viable bacteria and bacterial LPS during physiological mechanical forces, such as mastication and teeth brushing.

Keywords: Oncostatin M; barrier break; epithelial discontinuity; mechanical damages; neutrophils; stretching; tight junctions; tissue fracture.

Publication types

  • Review

MeSH terms

  • Bacteremia* / pathology
  • Gingiva
  • Humans
  • Inflammation / pathology
  • Lipopolysaccharides / pharmacology
  • Periodontitis* / pathology

Substances

  • Lipopolysaccharides

Grants and funding

The work was funded by the European Commissions EU H2020-FETOPEN-2018-2019-2020-01; 861878 “NeutroCure” to Martin Herrmann, by the Volkswagen-Stiftung (Grant 97744) to Martin Herrmann, by the Deutsche Forschungsgemeinschaft (DFG) SCHA 2040/1-1 to C.S., FOR 2886 PANDORA subproject B3 to Martin Herrmann, CRC1181-261193037 subproject C03 to Martin Herrmann.